The online version of this article (doi:10.1186/1475-2840-11-113) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
TR: conception and design, data interpretation, manuscript writing and final approval of manuscript; WM: conception and design, data analysis, manuscript writing, final approval of manuscript; LH and GM: advice with protein assay and data interpretation; LB: conception and design, assembly of data and data interpretation, manuscript review, final approval of manuscript. All authors read and approved the final manuscript.
Vascular calcification is one of the common complications in diabetes mellitus. Many studies have shown that high glucose (HG) caused cardiovascular calcification, but its underlying mechanism is not fully understood. Recently, medial calcification has been most commonly described in the vessels of patients with diabetes. Chondrocytes were involved in the medial calcification. Recent studies have shown that the conversion into mesenchymal stem cells (MSCs) via the endothelial-to-mesenchymal transition (EndMT) could be triggered in chondrocytes. Our previous research has indicated that HG induced EndMT in human aortic endothelial cells (HAECs). Therefore, we addressed the question of whether HG-induced EndMT could be transitioned into MSCs and differentiated into chondrocytes.
HAECs were divided into three groups: a normal glucose (NG) group, HG group (30 mmol/L), and mannitol (5.5 mmol/L NG + 24.5 mmol/L) group. Pathological changes were investigated using fluorescence microscopy and electron microscopy. Immunofluorescence staining was performed to detect the co-expression of endothelial markers, such as CD31, and fibroblast markers, such as fibroblast-specific protein 1 (FSP-1). The expression of FSP-1 was detected by real time-PCR and western blots. Endothelial-derived MSCs were grown in MSC medium for one week. The expression of the MSCs markers STRO-1, CD44, CD10 and the chondrocyte marker SOX9 was detected by immunofluorescence staining and western blots. Chondrocyte expression was detected by alcian blue staining. Calcium deposits were analyzed by alizarin red staining.
The incubation of HAECs exposed to HG resulted in a fibroblast-like phenotype. Double staining of the HAECs indicated a co-localization of CD31 and FSP-1. The expression of FSP-1 was significantly increased in the HG group, and the cells undergoing EndMT also expressed STRO-1, CD44 and SOX9 compared with the controls (P < 0.05). Additionally, alcian blue staining in the HG group was positive compared to the NG group. Consistent with the evaluation of SOX9 expression, calcium deposits analyzed by alizarin red staining were also enhanced by the HG treatment. Specifically, we showed that HG-induced EndMT is accompanied by the activation of the canonical Snail pathway.
Our study demonstrated that HG could induce endothelial cells transdifferentiation into chondrocyte-like cells via the EndMT, which is mediated in part by the activation of the Snail signaling pathway.
Authors’ original file for figure 112933_2012_546_MOESM1_ESM.pdf
Authors’ original file for figure 212933_2012_546_MOESM2_ESM.pdf
Authors’ original file for figure 312933_2012_546_MOESM3_ESM.pdf
Authors’ original file for figure 412933_2012_546_MOESM4_ESM.pdf
Authors’ original file for figure 512933_2012_546_MOESM5_ESM.tiff
Authors’ original file for figure 612933_2012_546_MOESM6_ESM.tiff
Authors’ original file for figure 712933_2012_546_MOESM7_ESM.pdf
Authors’ original file for figure 812933_2012_546_MOESM8_ESM.tiff
Authors’ original file for figure 912933_2012_546_MOESM9_ESM.pdf
Authors’ original file for figure 1012933_2012_546_MOESM10_ESM.tiff
Saleh N, Petursson P, Lagerqvist B, Skúladóttir H, Svensson A, Eliasson B, Gudbjörnsdottir S, Eeg-Olofsson K, Norhammar A: Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment. Diabetologia. 2012, 55: 2109-2117. 10.1007/s00125-012-2565-6. CrossRefPubMed
Li J, Qu X, Yao J, Caruana G, Ricardo SD, Yamamoto Y, Yamamoto H, Bertram JF: Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes. 2010, 59: 2612-2624. 10.2337/db09-1631. PubMedCentralCrossRefPubMed
Widyantoro B, Emoto N, Nakayama K, Anggrahini DW, Adiarto S, Iwasa N, Yagi K, Miyagawa K, Rikitake Y, Suzuki T, Kisanuki YY, Yanagisawa M, Hirata K: Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation. 2010, 121: 2407-2418. 10.1161/CIRCULATIONAHA.110.938217. CrossRefPubMed
Kageyama S, Yokoo H, Tomita K, Kageyama-Yahara N, Uchimido R, Matsuda N, Yamamoto S, Hattori Y: High glucose-induced apoptosis in human coronary artery endothelial cells involves up-regulation of death receptors. Cardiovasc Diabetol. 2011, 4: 73. CrossRef
Thomsen SB, Rathcke CN, Zerahn B, Vestergaard H: Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease. Cardiovasc Diabetol. 2010, 9: 86-10.1186/1475-2840-9-86. PubMedCentralCrossRefPubMed
Tang RN, Lv LL, Zhang JD, Dai HY, Li Q, Zheng M, Ni J, Ma KL, Liu BC: Effect of angiotensis II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic rats. Int J Cardio. 2011, in press
Medici D, Kalluri R: Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. Semin Cancer Biol. 2012, in press
Sueyoshi T, Yamamoto K, Akiyama H: Conditional deletion of Tgfbr2 in hypertrophic chondrocytes delays terminal chondrocyte differentiation. Matrix Biol. 2012, in press
- High glucose mediates endothelial-to-chondrocyte transition in human aortic endothelial cells
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II